Community-Associated CMRSA-10 (USA-300) is the Predominant Strain Among Methicillin-Resistant Staphylococcus aureus Strains Causing Skin and Soft Tissue Infections in Patients Presenting to the Emergency Department of a Canadian Tertiary Care Hospital

Journal of Emergency Medicine

Volumn 38, Issue 1, 2010, Pages 6-11

  Al Rawahi, Ghada N ^a   Reynolds, Steve ^a   Porter, Susan D ^a,b   Forrester, Leslie ^c   Kishi, Leane ^b   Chong, Tiffany ^b   Bowie, William R ^a   Doyle, Patrick W ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

community associated MRSA; emergency department; Panton Valentine leukocidin; skin and soft tissue infection

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS 10; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SKIN INFECTION; SOFT TISSUE INFECTION; TERTIARY HEALTH CARE;

EID: 74249113690     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.09.030     Document Type: Article

References (39)

1. Gorak E.J., Yamada S.M., and Brown J.D. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 29 (1999) 797-800
2. Kluytmans-Vandenbergh M.F., and Kluytmans J.A. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 12 Suppl 1 (2006) 9-15
3. Carleton H.A., Diep B.A., Charlebois E.D., Sensabaugh G.F., and Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 190 (2004) 1730-1738
4. Charlebois E.D., Bangsberg D.R., Moss N.J., et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 34 (2002) 425-433
5. Boussaud V., Parrot A., Mayaud C., et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidinsecreting Staphylococcus aureus. Intensive Care Med 29 (2003) 1840-1843
6. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 282 (1999) 1123-1125
7. Seybold U., Kourbatova E.V., Johnson J.G., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 42 (2006) 647-656 [Epub 2006 Jan 25]
8. Matsuhashi M., Song M.D., Ishino F., et al. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to betalactam antibiotics in Staphylococcus aureus. J Bacteriol 167 (1986) 975-980
9. Ito T., Katayama Y., Asada K., et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45 (2001) 1323-1336
10. Katayama Y., Ito T., and Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin-resistance in Staphylococcus aureus. Antimicrob Agents Chemother 44 (2000) 1549-1555
11. Ma X.X., Ito T., Tiensasitorn C., et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 46 (2002) 1147-1152
12. Beilman G.J., Sandifer G., Skarda D., et al. Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an Army Community Hospital. Surg Infect (Larchmt) 6 (2005) 87-92
13. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352 (2005) 468-475
14. Ellis M.W., Hospenthal D.R., Dooley D.P., Gray P.J., and Murray C.K. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 39 (2004) 971-979
15. Minnesota Department of Health. Community-associated methicillin-resistant Staphylococcus aureus in Minnesota. Dis Control Newsl 32 (2004) 61-72
16. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health careassociated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
17. Said-Salim B., Mathma B., and Kreiswirth B.N. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 24 (2003) 451-455
18. Daum R.S., Ito T., Hiramatsu K., et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186 (2002) 1344-1347
19. Chambers H.F. Community-associated MRSA-resistance and virulence converge. N Engl J Med 352 (2005) 1485-1487
20. Gilbert M., MacDonald J., Gregson D., et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 175 (2006) 149-154
21. Mulvey M.R., MacDougall L., Cholin B., Horsman G., Fidyk M., Woods S., and Saskatchewan CA-MRSA Study Group. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 11 (2005) 844-850
22. Wylie J.L., and Nowicki D.L. Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada. J Clin Microbiol 43 (2005) 2830-2836
23. Bannerman T.L., Hancock G.A., Tenover F.C., and Miller J.M. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 33 (1995) 551-555
24. Simor A.E., Ofner-Agostini M., Bryce E., McGeer A., Paton S., Mulvey M.R., Canadian Hospital Epidemiology Committee and Canadian Nosocomial Infection Surveillance Program, and Health Canada. Laboratory Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of national surveillance, 1995-1999. J Infect Dis 186 (2002) 652-660
25. McDougal L.K., Steward C.D., Killgore G.E., Chaitram J.M., McAllister S.K., and Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41 (2003) 5113-5120
26. Okuma K., Iwakawa K., Turnidge J.D., et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40 (2002) 4289-4294
27. Lina G., Piémont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29 (1999) 1128-1132
28. Fiebelkorn K.R., Crawford S.A., McElmeel M.L., and Jorgensen J.H. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 41 (2003) 4740-4744
29. Tenover F.C., McDougal L.K., Goering R.V., et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 44 (2006) 108-118
30. Frazee B.W., Lynn J., Charlebois E.D., Lambert L., Lowery D., and Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 45 (2005) 311-320
31. Diep B.A., Sensabaugh G.F., Somboona N.S., Carleton H.A., and Perdreau-Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for panton-valentine leucocidin. J Clin Microbiol 42 (2004) 2080-2084
32. Ofner-Agostini M., Simor A.E., Mulvey M., et al., Canadian Nosocomial Infection Surveillance Program, Health Canada. Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people. Infect Control Hosp Epidemiol 27 (2006) 204-207
33. Cribier B., Prevost G., Couppie P., Finck-Barbancon V., Grosshans E., and Piemont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections?. An epidemiological and experimental study. Dermatology 185 (1992) 175-180
34. Howden B.P., and Grayson M.L. Dumb and dumber-the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis 42 (2006) 394-400
35. Stevens D.L. The role of vancomycin in the treatment paradigm. Clin Infect Dis 42 Suppl 1 (2006) S51-S57
36. Barton M., Hawkes M., Moore D., et al. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol 17 Suppl C (2006) 4C-24C
37. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
38. Zaoutis T.E., Toltzis P., Chu J., et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J 25 (2006) 343-348
39. Kourbatova E.V., Halvosa J.S., King M.D., Ray S.M., White N., and Blumberg H.M. Emergences of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 33 (2005) 385-391